Clinical Study of a New Pneumococcal Vaccine in Adults 60 through 64 Years of Age

A Phase 2, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 60 Through 64 Years of Age

Category & Conditions:
Vaccine-related Conditions
Medicine:
PF-06482077
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
B7471002
Open Plain Language Summary Result:Click here